Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 2Phase 2/3 2Phase 1 2Phase EARLY_PHASE1 1Phase 1/2 1

Status

Recruiting 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 15Neoplasm Metastasis 13Squamous Cell Carcinoma of Head and Neck 11Neoplasms 11Prostatic Neoplasms 10Breast Neoplasms 9Recurrence 7Ovarian Neoplasms 7Myasthenia Gravis 7Lung Neoplasms 7Leukemia, Myeloid, Acute 7Stomach Neoplasms 6Head and Neck Neoplasms 6Colorectal Neoplasms 6Lymphoma, Large B-Cell, Diffuse 5Fatigue 5Pancreatic Neoplasms 4Oropharyngeal Neoplasms 4Melanoma 4Fallopian Tube Neoplasms 4Colonic Neoplasms 4Urinary Bladder Neoplasms 3Rectal Neoplasms 3Peritoneal Neoplasms 3Mouth Neoplasms 3Glioblastoma 3Cholangiocarcinoma 3Carcinoma, Hepatocellular 3Anorexia 3Adenocarcinoma Of Esophagus 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Cachexia × 90 days × Clear all
NCT06989437 2026-05-20

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

Pfizer

Phase 2/3 Recruiting
982 enrolled
Gastrointestinal

Anorexia, Cachexia, Fatigue, Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms, Weight Loss

NCT07112196 2026-05-20

VINCIT

CatalYm GmbH

Phase 2/3 Recruiting
518 enrolled

Anorexia, Cachexia, Neoplasms, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡